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Abstract
Coupling between G-protein-coupled receptors (GPCRs) and the G proteins is a key step in 
cellular signaling. Despite extensive experimental and computational studies, the mechanism of 
specific GPCR-G protein coupling remains poorly understood. This has greatly hindered effective 
drug design of GPCRs that are primary targets of ~1/3 of currently marketed drugs. Here, we have 
employed all-atom molecular simulations using a robust Gaussian accelerated molecular dynamics 
(GaMD) method to decipher the mechanism of the GPCR-G protein interactions. Adenosine 
receptors (ARs) were used as model systems based on very recently determined cryo-EM 
structures of the A1AR and A2AAR coupled with the Gi and Gs proteins, respectively. Changing 
the Gi protein to the Gs led to increased fluctuations in the A1AR and agonist adenosine (ADO), 
while agonist 5’-N-ethylcarboxamidoadenosine (NECA) binding in the A2AAR could be still 
stabilized upon changing the Gs protein to the Gi. Free energy calculations identified one stable 
low-energy conformation for each of the A1AR-Gi and A2AAR-Gs complexes as in the cryo-EM 
structures, similarly for the A2AAR-Gi complex. In contrast, the ADO agonist and Gs protein 
sampled multiple conformations in the A1AR-Gs system. GaMD simulations thus indicated that 
the A1AR preferred to couple with the Gi protein to the Gs, while the A2AAR could couple with 
both the Gs and Gi proteins, being highly consistent with experimental findings of the ARs. More 
importantly, detailed analysis of the atomic simulations showed that the specific AR-G protein 
coupling resulted from remarkably complementary residue interactions at the protein interface, 
involving mainly the receptor transmembrane 6 helix and the Gα α5 helix and α4-β6 loop. In 
summary, the GaMD simulations have provided unprecedented insights into the dynamic 
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G-protein-coupled receptors (GPCRs) are key cellular signaling proteins and represent 
primary targets of ~1/3 of currently marketed drugs.1 Particularly, four subtypes (A1, A2A, 
A2B, and A3) of GPCRs mediate the effects of adenosine, an endogenous nucleoside 
modulator that plays a critical role in cytoprotective function. Adenosine receptors (ARs) 
have emerged as important therapeutic targets for treating many human diseases such as 
cardiac ischemia, neuropathic pain and cancer.2 During function, the A1AR and A3AR 
preferentially couple to the Gi/o proteins, while the A2AAR and A2BAR preferentially couple 
to the Gs proteins. Nevertheless, increasing evidence suggests that GPCRs including the ARs 
can couple to multiple G proteins.3-6
Few complex structures of GPCRs coupled with the G protein or its mimic have been 
determined using X-ray crystallography or cryo-EM so far.7-11 ARs are the sole subfamily 
of GPCRs that have structures in complex with different G proteins, i.e., the adenosine 
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(ADO)-bound A1AR coupled with the Gi protein10 and the 5’-N-
ethylcarboxamidoadenosine (NECA)-bound A2AAR coupled with an engineered Gs protein.
9 Both structures were obtained via cutting-edge cryo-EM and published very recently in 
2018. The GPCR-G protein complex structures provide valuable information about active 
conformations of the GPCRs and G proteins. However, they are rather static images. The 
dynamic mechanism of specific GPCR–G protein interactions remains unclear.
Experimental techniques including mutagenesis, nuclear magnetic resonance, hydrogen-
deuterium exchange mass spectrometry, double electron-electron resonance spectroscopy 
and structural biology have been utilized to investigate GPCR–G protein interactions.12-15 
While the C-terminal α5 helix in the Gα subunit (including residues H5.22–H5.26) has been 
suggested as the primary driver for specific receptor recognition, the Gα αN helix and 
receptor intracellular loop (ICL) 2 and transmembrane (TM) 6 helix (including residues 
6.29–6.40) further contribute to the GPCR–G protein coupling specificity. The Ballesteros 
and Weinstein (BW) numbering16 and common Gα numbering (CGN)17 are used here for 
residues in the GPCRs and G proteins, respectively. In addition, dynamic regions in the 
complex and agonist binding can be crucial for the coupling through allosteric modulation.
13-14
A bioinformatics approach has been applied to determine a selectivity barcode (patterns of 
amino acids) of GPCR–G protein coupling.18 While universally conserved residues in the 
barcode allow GPCRs to bind and activate G protein in a similar manner, different receptors 
recognize the unique positions of the G-protein barcode through distinct residues. Molecular 
dynamics (MD) simulations have identified several important regions for coupling of the G 
protein with activated GPCRs, including the receptor TM6 and Gα α5 helices.19-21 MD 
simulations have shown that conformational dynamics of the GPCR-G protein complex 
depends on the bound ligands.22-23 Moreover, MD simulations have suggested that the 
binding of the active GPCR is necessary for nucleotide release from the G protein.24-27 
However, due to limited timescales, conventional MD (cMD) simulations often suffer from 
insufficient sampling, precluding proper free energy calculations to characterize GPCR-G 
protein interactions quantitatively.
To overcome the limitations of cMD, enhanced sampling methods have been applied to 
investigate GPCR–G protein interactions. Umbrella sampling has been used to calculate free 
energy profiles of the TM6 outward movement during receptor coupling to the G proteins.21 
Metadynamics simulations have been performed to investigate the dynamic effects of 
different GPCR ligands and intracellular binding partners28 and examine differences of 
GPCRs coupled by the G protein versus its mimetic nanobody.29 Nevertheless, these 
enhanced simulation methods require predefined collective variables and may apply 
constrains on the conformational space of the proteins. In this regard, a robust Gaussian 
accelerated MD (GaMD) method has been developed to allow for unconstrained enhanced 
sampling and free energy calculations of large biomolecules.30-32 GaMD has been applied to 
successfully simulate protein folding,30-31 protein-ligand binding and unbinding,30-31, 33 
GPCR activation,33 large-scale conformational transitions of the CRISPR-Cas9 gene-editing 
system,34 T cell receptor signaling protein,35 human dystonia related protein,36 and so on. 
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Notably, GaMD has been recently applied to capture spontaneous binding of the G-protein 
mimetic nanobody to a muscarinic GPCR.37
In this study, we have employed all-atom enhanced sampling simulations using the robust 
GaMD method on the latest cryo-EM structures of native ADO-A1AR-Gi and NECA-
A2AAR-Gs protein complexes, as well as “decoy” complexes generated by switching the G 
proteins (Table 1 and Figure S1A in Supporting Information). A total of four simulation 
systems thus included the ADO-A1AR-Gi, NECA-A2AAR-Gs, ADO-A1AR-Gs and NECA-
A2AAR-Gi protein complexes. To focus on the receptor-G protein coupling, we drop agonist 
in the complex notations for simplicity thereafter. However, note that the G protein coupling 
specificity may depend on the bound agonist in the receptor.4-5 A computational model was 
prepared for the receptor-G protein complexes in explicit lipids and solvent (Figure S1B). 
The GaMD simulations allowed us to characterize structural flexibility and low-energy 
conformations of the AR-G protein complexes, which provided important insights into the 
mechanism of specific GPCR–G protein interactions.
Materials and Methods
Gaussian accelerated molecular dynamics (GaMD).
GaMD enhances the conformational sampling of biomolecules by adding a harmonic boost 
potential to reduce the system energy barriers.30 When the system potential V( r ) is lower 
than a reference energy E, the modified potential V∗( r ) of the system is calculated as:
V∗( r ) = V( r ) + ΔV( r )
ΔV( r ) =
1
2 k E − V( r )
2, V( r ) < E
0, V( r ) ≥ E,
(1)
Where k is the harmonic force constant. The two adjustable parameters E and k are 
automatically determined on three enhanced sampling principles. First, for any two arbitrary 
potential values v1( r ) and v2( r ) found on the original energy surface, if V1( r ) < V2( r ), ΔV 
should be a monotonic function that does not change the relative order of the biased 
potential values; i.e., V1
∗( r ) < V2
∗( r ). Second, if V1( r ) < V2( r ), the potential difference 
observed on the smoothened energy surface should be smaller than that of the original; i.e., 
V2
∗( r ) − V1
∗( r ) < V2( r ) − V1( r ). By combining the first two criteria and plugging in the 
formula of V∗( r ) and ΔV, we obtain
Vmax ≤ E ≤ Vmin +
1
k , (2)
Where Vmin and Vmax are the system minimum and maximum potential energies. To ensure 
that Eq. 2 is valid, k has to satisfy: k ≤ 1/(Vmax − Vmin. Let us define: k = k0 · 1/(Vmax − 
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Vmin, then 0 < k0 ≤ 1. Third, the standard deviation (SD) of ΔV needs to be small enough 
(i.e. narrow distribution) to ensure accurate reweighting using cumulant expansion to the 
second order: σΔV = k(E − Vavg)σV ≤ σ0, where Vavg and σV are the average and SD of 
ΔVwith σ0 as a user-specified upper limit (e.g., 10kBT) for accurate reweighting. When E is 
set to the lower bound E = Vmax according to Eq. 2, k0 can be calculated as







Alternatively, when the threshold energy E is set to its upper bound E = Vmin + 1/k, k0 is set 
to:







If k0″is calculated between 0 and 1. Otherwise, k0is calculated using Eq. 3.
Energetic Reweighting of GaMD Simulations.
For energetic reweighting of GaMD simulations to calculate potential of mean force (PMF), 
the probability distribution along a reaction coordinate is written as p*(A) . Given the boost 
potential ΔV(r) of each frame, p*(A) can be reweighted to recover the canonical ensemble 
distribution p(A), as:






, j = 1, …, M, (5)
where M is the number of bins, β = kBT and ⟨eβΔV(r)⟩j is the ensemble-averaged Boltzmann 
factor of ΔV(r) for simulation frames found in the jth bin. The ensemble-averaged 
reweighting factor can be approximated using cumulant expansion:
〈eβΔV(r)〉 = exp ∑k = 1∞ β
k
k! Ck , (6)
where the first two cumulants are given by:
C1 = 〈ΔV〉,
C2 = 〈ΔV
2〉 − 〈ΔV〉2 = σv
2 .
(7)
The boost potential obtained from GaMD simulations usually follows near-Gaussian 
distribution 32. Cumulant expansion to the second order thus provides a good approximation 
for computing the reweighting factor 30, 38. The reweighted free energy F(A) = −kBT ln p(A) 
is calculated as:
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F(A) = F∗(A) − ∑k = 12 β
k
k! Ck + Fc, (8)
where F*(A) = −kBT ln p*(A) is the modified free energy obtained from GaMD simulation 
and Fc is a constant.
System Setup.
Cryo-EM structures of the A1AR-Gi (PDB: 6D9H)10 and A2AAR-Gs (PDB: 6GDG)9 were 
used for setting up simulation systems. Nanobody Nb35 in the cryo-EM structure of the 
A2AAR-Gs was deleted for simulation. In the 6GDG cryo-EM structure, a number of 
residues were missing in extracellular loop (ECL) 2 and the C terminus of the A2AAR. 
Because the A2AAR receptor configuration in the 6GDG cryo-EM structure is very similar 
to the X-ray structure of A2AAR bound by the mini-Gs protein (PDB: 5G53)39, we added the 
missing residues in the ECL2 and the C terminus of the A2AAR using atomic coordinates 
from the 5G53 X-ray structure after aligning the receptor transmembrane (TM) domain of 
the two structures. Initial models of the A1AR-Gs and A2AAR-Gi protein complexes were 
obtained by switching the G proteins in the A2AAR-Gs and A1AR-Gi complexes after 
aligning the receptor TM domain (Figure S1A in Supporting Information). There was no 
steric clash between the ARs and G proteins. We calculated the number of salt-bridge, 
hydrogen-bonding and hydrophobic residue interactions between the receptors and G 
proteins at the interface in the cryo-EM (native) and computationally generated (decoy) 
complex structures using the LIGPLOT software.40 As summarized in Table S1, the A1AR-
Gs decoy complex exhibited actually the largest number of residue interactions among the 
four systems and the A2AAR-Gi decoy complex showed similar number of interactions as 
the native A1AR-Gi complex. Therefore, all four complex structures served as good starting 
points for computer simulations.
According to previous findings, intracellular loop (ICL) 3 is highly flexible and removal of 
ICL3 does not appear to affect GPCR function.25, 41 The ICL3 was thus omitted as in the 
cryo-EM structures for the simulations. 42 In addition, helical domains of the Gi and Gs 
proteins missing in the cryo-EM structures were not included in the simulation models.20 
This was based on earlier simulation of the β2AR-Gs complex, which showed that the helical 
domain fluctuated substantially.25 All chain termini were capped with neutral groups (acetyl 
and methylamide). All the disulphide bonds in the receptors and G proteins (i.e., Cys803.25-
Cys169ECL2 and Cys2606.61-Cys263ECL3 in the A1AR, Cys743.22-Cys146ECL2, Cys773.25-
Cys166ECL2, Cys71ECL1-Cys159ECL2 and Cys2596.61-Cys262ECL3 in the A2AAR, and 
Cys121-Cys149 in the Gβ subunit of the Gs protein) that were resolved in the cryo-EM 
structures were maintained in the simulations. Using the psfgen plugin in VMD,43 missing 
atoms in protein residues were added and all protein residues were set to the standard 
CHARMM protonation states at neutral pH. For each of the complex systems, the receptor 
was inserted into a palmitoyl-oleoyl-phosphatidyl-choline (POPC) bilayer with all 
overlapping lipid molecules removed using the membrane plugin in VMD. The system 
charges were then neutralized at 0.15M NaCl using the solvate plugin in VMD.43 The 
simulation systems were summarized in Table 1, with an example computational model 
shown in Supporting Information, Figure S1B.
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The CHARMM36 parameter set44-46 was used for the adenosine receptors, G proteins and 
POPC lipids. Force field parameters of agonists ADO and NECA were obtained from the 
CHARMM ParamChem web server.47-48 GaMD simulations of the AR-G protein systems 
followed a similar protocol used in previous studies of GPCRs.33, 37 For each of the AR-G 
protein complex systems, initial energy minimization, thermalization, and 20ns cMD 
equilibration were performed using NAMD2.12.49 A cutoff distance of 12 Å was used for 
the van der Waals and short-range electrostatic interactions and the long-range electrostatic 
interactions were computed with the particle-mesh Ewald summation method.50 A 2-fs 
integration time step was used for all MD simulations and a multiple-time-stepping 
algorithm was used with bonded and short-range non-bonded interactions computed every 
time step and long-range electrostatic interactions every two time steps. The SHAKE 
algorithm51 was applied to all hydrogen-containing bonds. The NAMD simulation started 
with equilibration of the lipid tails. With all other atoms fixed, the lipid tails were energy 
minimized for 1,000 steps using the conjugate gradient algorithm and melted with a constant 
number, volume, and temperature (NVT) run for 0.5 ns at 310 K. The four systems were 
further equilibrated using a constant number, pressure, and temperature (NPT) run at 1 atm 
and 310 K for 10 ns with 5 kcal/(mol· Å2) harmonic position restraints applied to the protein 
and ligand atoms. The system volume was found to decrease with a flexible unit cell applied 
and level off with 10-ns NPT run, suggesting that solvent and lipid molecules in the system 
were well equilibrated. Final equilibration of each system was performed using a NPT run at 
1 atm pressure and 310 K for 0.5 ns with all atoms unrestrained. After energy minimization 
and system equilibration, conventional MD simulations were performed on each system for 
20 ns at 1 atm pressure and 310 K with a constant ratio constraint applied on the lipid 
bilayer in the X-Y plane.
With the NAMD output structure, along with the system topology and CHARMM36 force 
field files, the ParmEd tool in the AMBER package was used to convert the simulation files 
into the AMBER format.52 The GaMD module implemented in the GPU version of 
AMBER1830, 52 was then applied to perform the GaMD simulation, which included a 8-ns 
short cMD simulation used to collect the potential statistics for calculating GaMD 
acceleration parameters, a 64-ns equilibration after adding the boost potential, and finally 
three independent 300-ns GaMD production simulations with randomized initial atomic 
velocities. All GaMD simulations were run at the “dual-boost” level by setting the reference 
energy to the lower bound. One boost potential is applied to the dihedral energetic term and 
the other to the total potential energetic term. The average and SD of the system potential 
energies were calculated every 800,000 steps (1.6 ns) for all simulation systems. The upper 
limit of the boost potential SD, σ0 was set to 6.0 kcal/mol for both the dihedral and the total 
potential energetic terms. Similar temperature and pressure parameters were used as in the 
NAMD simulations. A list of GaMD production simulations on the different ARs-G proteins 
complex systems is listed in Table 1.
Simulation Analysis.
CPPTRAJ53 and VMD43 were used to analyze the GaMD simulations. Important reaction 
coordinates were identified from the simulation trajectories such that they involved system 
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dynamic regions and could be used to differentiate conformational states of the receptor-G 
protein complexes. The observed dynamic regions included the agonists, the receptor TM6 
helix and ECL2, and the C terminus of the Gα α5 helix. Therefore, the root-mean square 
deviations (RMSDs) of the agonist and ECL2 relative to the simulation starting structures 
and the distance between the receptor TM3 and TM6 intracellular ends were selected as 
reaction coordinates. Moreover, the distance between the conserved NPxxY motif in the 
TM7 intracellular end of the receptors and the C terminus of the Gα α5 helix was used to 
characterize the AR-G protein interactions. Particularly, distances were calculated between 
the Cα atoms of residues Arg3.50 and Glu6.30, the center-of-mass (COM) distance between 
the receptor NPxxY motif and the last 5 residues of the Gα α5 helix, and the COM distance 
between the Gα (excluding residues in the αN helix) and Gβ (excluding residues 2-45 in the 
N-terminus) subunits. Root-mean-square fluctuations (RMSFs) were calculated for the 
protein residues and ligands, averaged over three independent GaMD simulations and color 
coded for schematic representation of each complex system (Figure 1). Time courses of 
these reaction coordinates obtained from the GaMD simulation were plotted in Supporting 
Information, Figures S2-S5. The representative low-energy conformations of the AR-G 
protein complexes were used to compute their residue contact network at the protein 
interface. The residue contact network between the AR and G protein was computed using 
van der Waals contacts between the residue atoms. A pair of residues are in contact if the 
Euclidean distance between any pair of heavy atoms from the two residues is within the van 
der Waals interaction distance (that is, the sum of the van der Waals radii of the atoms plus 
0.6 Å), as described in Reference.54 For two-dimensional visualization, software 
Cytoscape55 was utilized to plot the residue contact network.
The PyReweighting38 toolkit was applied to reweight GaMD simulations to recover the 
original free energy or potential of mean force (PMF) profiles of the four AR-G protein 
complex systems. PMF profiles were computed using the combined trajectories from all the 
three independent 300 ns GaMD simulations for each system. A bin size of 1.0 Å was used 
for the distances and RMSDs, and 5° for the Gα α5 orientation angle. The cutoff was set to 
500 frames for 2D PMF calculations. The 2D PMF profiles were obtained for each 
simulation system regarding agonist RMSD relative to the cryo-EM conformation and the 
AR:NPxxY-G:α5 distance (Figure 2), RMSD of the helix region in ECL2 relative to the 
cryo-EM structure and the AR:NPxxY-G:α5 distance (Figures 4A and S6 in Supporting 
Information), the distance between atom NE1 of Trp156ECL2 and atom O of Gly163ECL2 
and RMSD of the helix region in ECL2 relative to the cryo-EM structure (Figure S7 in 
Supporting Information), the Arg3.50-Glu6.30 and the AR:NPxxY-G:α5 distances (Figures 
4B and S8 in Supporting Information), the Gα α5 orientation angle and the Arg3.50-Glu6.30 
distance (Figures 4C and S9 in Supporting Information), and increase of the Gα-Gβ distance 
and the Arg3.50-Glu6.30 distance (Figures 4D and S10 in Supporting Information).
Results
Variations of structural flexibility in different adenosine receptor-G protein complexes.
We first analyzed structural flexibility of both the adenosine receptors and G proteins in their 
complexes. In GaMD simulations of the A1AR-Gi and A2AAR-Gs complexes, the receptors 
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underwent small fluctuations except the extracellular loop 2 (ECL2) and TM6 intracellular 
end (Figure S11 in Supporting Information). Overall, the G proteins exhibited higher 
flexibility than the receptors, especially in the α5 helix, α4-β6 loop and α4-β5 loop in the 
Gα subunit and terminal arms of the Gβγ subunits on the protein surface. Both the A1AR 
and A2AAR showed flexibility change upon switching of the G proteins. For the A1AR, 
changing the Gi protein to the Gs led to increased fluctuations in the ADO agonist and the 
receptor ECL2, TM6 intracellular end and helix 8 (H8) (Figure 1A). These motifs were 
suggested to be important in previous studies for activation of the A1AR and receptor 
coupling with the G protein.10, 56 For the A2AAR, changing the Gs protein to the Gi, 
however, appeared to also stabilize the receptor with similar fluctuations in the latter, other 
than the ECL2 and intracellular loop 2 (ICL2) regions (Figure 1B).
Next, we examined flexibility change of the G proteins upon coupling to the different 
receptors. In the Gs protein, the C-terminus of the Gα α5 helix exhibited higher fluctuations 
when the A2AAR was changed to the A1AR (Figure 1C). In the Gi protein, while the Gα α5 
helix became stabilized with lower fluctuations, the α4-β5 loop and switch ΙΙΙ exhibited 
higher flexibility when the A1AR was changed to the A2AAR (Figure 1D). These regions 
were shown earlier to be important in activation and receptor recognition of the G protein.
25, 57
Distinct binding modes of the G proteins and agonists in adenosine receptors.
Free energy profiles were calculated from GaMD simulations to identify low-energy 
conformations and binding modes of the GPCR-G protein complexes. RMSD of the agonist 
relative to the cryo-EM structures and the distance between the receptor NPxxY motif in the 
TM7 intracellular end and the C-terminus of the Gα α5 helix were first used as the reaction 
coordinates. In the A1AR-Gi and A2AAR-Gs protein complexes, both the G proteins and 
agonists maintained their cryo-EM conformations (Figures 2A and 2B, Table 1). In the 
A2AAR-Gi complex, the NECA agonist maintained the cryo-EM conformation as in the 
A2AAR-Gs complex, but the Gi protein sampled a different state with the receptor:NPxxY-
Gα α5 distance decreased to ~11.2 Å (Figure 2C). The Gαi α5 helix moved ~2 Å towards 
the TM7 NPxxY motif of the A2AAR relative to the Gαs α5 helix in the A2AAR-Gs structure 
(Table 1). Nevertheless, the A2AAR-Gi complex adopted a stable low-energy conformation 
in the free energy profile (Figure 2C).
In the A1AR-Gs complex, the ADO agonist exhibited fluctuations during GaMD 
simulations. The simulations included 8 ns short cMD, 64 ns GaMD equilibration after 
adding the boost potential and then three independent 300 ns GaMD production runs. 
Analysis of the simulation trajectories showed that RMSD of the ADO agonist reached ~5.2 
Å during GaMD equilibration and up to ~12 Å in the GaMD production runs (Figure S4 in 
Supporting Information). Further PMF calculations identified low-energy conformational 
states of the ADO agonist. ADO sampled two representative conformations, denoted “L1” 
and “L2”, for which agonist RMSD was ~3.0 Å and ~7.5 Å, respectively (Figure 2D). The 
“L1” conformation of ADO was similar to the cryo-EM structure with slight sliding of the 
purine ring by ~2 Å at the orthosteric site (Figure 3A). In the “L2” conformation, ADO 
formed interactions with residues Tyr1.35 and Tyr7.36 in the “sub-pocket 2” of the A1AR 
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described earlier (Figure S12 in Supporting Information).42 The Gs protein sampled two 
low-energy conformational states, which were similar to cryo-EM conformations of the Gi 
protein in the A1AR-Gi complex and the Gs protein in the A2AAR-Gs complex and thus 
denoted as Gi and Gs in Figure 2D. The receptor:NPxxY-Gα:α5 distance was ~11.8 Å and 
~13.5 Å in the Gi- and Gs-bound A1AR, respectively (Figure 2D and Table 1). It is 
important to note that GaMD simulations of the A1AR-Gs system were not converged 
compared with simulations of the other systems. In this regard, the calculated free energy 
profiles (especially the energy barriers) were not exactly accurate. Nevertheless, we were 
able to identify relatively low energy wells from the PMF profiles and then representative 
conformational states of the A1AR-Gs complex system.
High flexibility and conformational changes of ECL2 in the A1AR.
The ECL2 was suggested to be important for GPCR functions56 and observed to be highly 
flexible in the GaMD simulations. Thus, we analyzed its dynamics in detail here. In the 
A1AR, different conformational states of the ECL2 helix were identified from GaMD 
simulations, including the “open”, “semi-open” and “closed” state (Figure 3B). In 
comparison, the ECL2 in the A2AAR sampled only one low-energy conformational state 
(Figure S6 in Supporting Information). In the A1AR-Gi complex, the ECL2 sampled a 
distinct “semi-open” conformation with ~5.5 Å RMSD in the helix region compared with 
the “open” cryo-EM conformation (Figure S6A in Supporting Information), for which the 
ECL2 helix tilted towards the receptor TM bundle by ~4 Å (Figure 3B). In the A1AR-Gs 
system, the receptor ECL2 sampled the “open” and “closed” states (Figure 4A). In the 
“closed” state, the ECL2 helix tilted towards the receptor TM bundle by ~9 Å relative to the 
“open” cryo-EM conformation (Figure 3B). Meanwhile, the TM2 extracellular domain could 
move outwards by ~10 Å (Figure S7B in Supporting Information). Such movement was also 
observed during binding of a covalent antagonist DU172 to the A1AR that involved an 
induced fit mechanism.42, 58 In the “open” and “closed” conformational states of ECL2 in 
the A1AR, residue Trp156ECL2 formed different hydrogen bonds with Gly163ECL2 and 
Val166ECL2, respectively (Figure S7 in Supporting Information). Therefore, these residue 
interactions played a critical role in conformational change of ECL2 in the A1AR. This 
finding was consistent with previous mutagenesis experiments, suggesting that mutations of 
residues Trp156ECL2 and Val166ECL2 affected the allosteric modulation and activation of the 
A1AR.56, 59
Comparatively weak coupling between the A1AR and Gs protein.
Overall, the A1AR-Gi, A2AAR-Gs and A2AAR-Gi complexes appeared to be stable during 
the GaMD simulations (Table 1). Each of them sampled only one low-energy conformation 
in the free energy profiles calculated with different reaction coordinates, including the 
agonist RMSD (Figures 2), RMSD of the helix region in ECL2 relative to the cryo-EM/
simulation starting structures (Figure S6 in Supporting Information), the Arg3.50-Glu6.30 
distance (Figure S8 in Supporting Information), the Gα α5 orientation angle (Figure S9 in 
Supporting Information) and increase of the Gα-Gβ distance from the starting conformations 
(Figure S10 in Supporting Information). In comparison, coupling of the Gs protein to the 
A1AR was significantly weaker. The A1AR-Gs system deviated from the simulation starting 
structure, visiting multiple low-energy conformational states. In particular, the TM6 
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intracellular end of the A1AR sampled two distinct low-energy states. In the first state, the 
Arg3.50-Glu6.30 distance was ~17.5 Å, which is similar to that in the active cryo-EM 
structure (16.3 Å), thus here we referred to as “Active” state (Figure 4B). While the Arg3.50-
Glu6.30 distance in the second state was ~22.5 Å, which is larger than the “Active” state, 
thus hereafter we referred to as “Over-active” state (Figure 4B). The receptor TM6 
intracellular end moved ~5 Å away from the TM bundle in the “Over-active” state compared 
with the “Active” state (Figures 3C and 4B). When the A1AR visited the “Active” and 
“Over-active” states, the Gα α5 helix adopted an orientation angle of ~123° and ~130° 
(Figure 4C) and the distance between the Gα and Gβ subunits increased by ~1.2 Å and ~3.2 
Å, respectively (Figure 4D).
The above results suggested that the Gs protein could not stabilize the A1AR. On the other 
hand, the Gαs and Gβs subunits tended to dissociate from each other when the Gs protein 
coupled to the A1AR (Figure S10D in Supporting Information). In contrast, the Gαi and Gβi 
subunits formed closer interaction when the Gi protein coupled to the A1AR, for which the 
Gαi-Gβi distance decreased by ~1.3 Å in the energy minimum conformation of the A1AR-Gi 
complex (Figure S10A). Therefore, the A1AR induced closer interaction of the Gα and Gβ 
subunits in the Gi protein, but dissociation of the Gαs and Gβs subunits from each other 
(Table 1, Figure S10A and S10D in Supporting Information). In summary, coupling of 
A1AR to the Gs protein was weaker than to the Gi protein.
Mechanism of specific adenosine receptor-G protein interactions.
Sequence alignments of the ARs and G proteins (Figure S13 in Supporting Information) and 
detailed comparison of residue interactions at the protein interface (Figure 5) enabled us to 
identify the origin of specific AR-G protein interactions.10, 39, 54 In the A1AR-Gi and 
A2AAR-Gs complexes, analysis of low-energy conformations identified from the GaMD 
simulations highlighted specific residue interactions (Figures 5A and 5B) that were similar 
to those obtained previously by comparing the A1AR-Gi and β2AR-Gs experimental 
structures.10 The last five residues of the Gα α5 helix formed significantly stronger receptor 
interactions in the A1AR-Gi complex than in the A2AAR-Gs complex. Residue 
Asp351(GH5.22) in the Gi protein formed salt-bridge interactions with Arg3.53 and Lys8.49 
in the A1AR. In the Gs protein, residue Glu382 (GH5.24) formed similar salt-bridge 
interactions with Arg7.56 and Arg8.51 in the A2AAR. However, these five residues formed 
closer van der Waals interactions with the TM3, TM5, TM6 and H8 of the A1AR. Second, 
residues GH5.8–GH5.21 of the Gα α5 helix formed more interactions with the receptor 
ICL2 and TM5 helix in the A2AAR-Gs complex instead than in the A1AR-Gi complex. In 
addition, the α4–β6 loop of the G protein formed distinct interactions with the receptor TM5 
helix in the A2AAR-Gs complex compared with the A1AR-Gi complex. Residues His347 
(Gh4s6.13) and Tyr348 (Gh4s6.20) of the Gs protein formed non-polar interactions with 
Gln5.71 and Met5.72 in the A2AAR (Figure 5B). In contrast, residue Asp316 (Gh4s6.9) of the 
Gi protein formed polar interactions with residues Lys6.25 and Tyr6.26 in the A1AR (Figure 
5A).
In comparison, the A2AAR-Gi complex appeared to form more residue interactions at the 
protein interface (Figure 5C) than both the A1AR-Gi and A2AAR-Gs complexes. Notably, 
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the last five residues of Gαi α5 helix formed extensive polar and non-polar interactions with 
the TM3, TM6, TM7, ICL2 and H8 of the A2AAR. Residue Phe355 (GH5.26) formed close 
interactions with Lys 6.29, His6.32 and Ser6.36 of the A2AAR. Residues GH5.8-GH5.21 of the 
Gαi α5 helix formed additional interactions with H8 of the A2AAR, apart from those with 
the receptor TM5 and ICL2 as observed in the A1AR-Gi and A2AAR-Gs complexes. 
Furthermore, the β2-β3 loop of the Gi protein formed new interactions with the ICL2 of the 
A2AAR. Residue Asp194 (Gs2s3.2) formed a salt-bridge with Arg111ICL2 in the A2AAR. 
These interactions greatly contributed to strong coupling of the A2AAR and Gi protein, 
which showed stable low-energy conformations in the free energy profiles (e.g., Figure 2) 
and small fluctuations (Figure 1).
When the Gs protein coupled to the A1AR, residue interactions at the protein interface were 
decreased overall (Figure 5D). In the “Active” state, the TM6 helix of the A1AR formed 
significantly fewer interactions with the Gs protein (Figure 5D) than with the Gi protein 
(Figure 5A). The αN-β1, β2 sheet and β2-β3 loop of the Gs protein involving residues R38 
(Ghns1.2), A39 (Ghns1.3), H41 (GS1.2), D215 (Gs2s3.1) and V217 (GS3.1) formed new 
interactions with the TM2 helix and ICL2 of the A1AR (Figure 5D). However, both clusters 
of residues in the Gα α5 helix (GH5.8-GH5.21 and GH5.22-GH5.26) greatly reduced 
receptor interactions in the A1AR-Gs system compared with the A1AR-Gi and A2AAR-Gs 
complexes. Similar results were observed in the “Over-active” conformation of the A1AR-Gs 
system (Figure S14 in Supporting Information). Therefore, reduced residue interactions 
were found at the protein interface between the A1AR and Gs protein, leading to their 
weaker coupling compared with the other three AR-G protein complexes (Figure 5).
In summary, the ADO-bound A1AR preferred to bind the Gi protein to the Gs, while the 
A2AAR could bind both the Gs and Gi proteins (Figure 6). For the A1AR, when the Gi 
protein was changed to the Gs, the receptor ECL2 and TM6 intracellular end underwent 
higher fluctuations and sampled multiple conformational states, similarly for the agonist and 
G protein. The Gs protein could not stabilize ADO binding in the A1AR, and vice versa. 
Coupling of the A1AR to the Gs protein was significantly weaker than to the Gi protein. The 
Gαs and Gβs subunits tended to dissociate from each other (Figure 6A). In contrast, both the 
Gs and Gi proteins could stabilize agonist NECA binding in the A2AAR. The Gi protein 
became even more compact with decreased distance between the Gα and Gβ subunits in the 
NECA-bound A2AAR-Gi complex (Figure 6B).
Discussions
ARs are so far the only subfamily of GPCRs that have available experimental structures in 
complex with different G proteins, including the A1AR-Gi and A2AAR-Gs complexes. The 
AR-G protein complex structures were obtained via cutting-edge cryo-EM and published 
very recently in 2018. Using these cryo-EM structures together with A1AR-Gs and A2AAR-
Gi decoy complexes, we have performed all-atom enhanced simulations using the robust 
GaMD technique. Our GaMD simulations are shown to be converged according to time 
courses of system reaction coordinates in the AR-G protein complexes (Figures S2-S5 in 
Supporting Information) except the A1AR-Gs decoy complex with comparatively higher 
fluctuations (Figure S4 in Supporting Information). Nevertheless, the all-atom GaMD 
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enhanced simulations have allowed us to characterize the structural flexibility and low-
energy conformations of the different AR-G protein complexes, which provide valuable 
insights into the mechanism of specific GPCR-G protein interactions. Further detailed 
analysis of the AR-G protein complex simulations has highlighted a network of remarkable 
complementary residue interactions at the protein interface, which are important for specific 
G protein coupling to the A1AR and A2AAR.
The ADO-bound A1AR preferred to bind the Gi protein to the Gs. This was consistent with 
previous experimental studies that the A1AR coupled to different G proteins with the 
following rank order of “preference”: Gi>Gs>Gq, and the G protein coupling depends on the 
bound agonist in the receptor.4-5 Particularly, the NECA-bound A1AR was shown to 
preferentially couple to the Gi protein compared with the Gs protein.4 Considering similar 
binding affinities of ADO and NECA in the A1AR,60-61 the ADO-bound A1AR likely 
prefers to couple to the Gi protein as well. When the A1AR coupled with the Gs protein, the 
ADO agonist exhibited high fluctuations and sampled two different binding poses (“L1” and 
“L2”). In the “L2” binding pose, ADO formed interactions with residues Tyr1.35 and Tyr7.36 
in the sub-pocket 2 of the A1AR as described earlier.42 This was similar to the 5UIG X-ray 
structure of the A2AAR,62 in which the 8D1 antagonist interacted with the same residues of 
the A2AAR (Figure S12 in Supporting Information). While the ADO and NECA agonists 
which bind the A1AR and A2AAR in the cryo-EM structures, respectively, were used in the 
GaMD simulations, earlier experimental studies suggested that the coupling of different G 
proteins to GPCRs depends on the receptor agonist.63-65 For the A1AR, Cordeaux et al.4 
showed that a series of the N6-cyclopentyladenosine (CPA) and NECA agonist analogues 
have different efficacies or “strengths” at activation of the Gi, Gs and Gq proteins. Agonists 
with the highest efficacy such as NECA could activate all the Gi, Gs and Gq proteins. 
Agonists with mediate strengths such as 3’-deoxy-CPA (3’dCPA) could activate the Gi and 
Gs proteins. The weakest agonist such as 2’dCPA could activate only the Gi protein. The role 
of agonists on the selectivity of GPCR-G protein coupling will be investigated in future 
studies. The ECL2 of the A1AR was highly flexible (Figures 1 and S11 in Supporting 
Information) and sampled “open”, “semi-open” and “closed” conformations (Figure S6 in 
Supporting Information). Both experimental and computational studies suggested that 
flexibility of the ECL2 was important for activation and allosteric modulation of the A1AR.
59, 66-67 Therefore, highly flexibility of the ECL2 contributed to activation of the A1AR and 
receptor coupling to the G protein.
The A2AAR could couple to both the Gs and Gi proteins. This correlated with a recent 
experimental study that the A2BAR coupled with both the Gs and Gi proteins in human cells.
3 The A2BAR was able to activate different downstream signaling pathways via different G 
proteins (including the Gs and Gi) in the same cell type (e.g., HEK293 kidney and T24 
bladder cancer cells) and couple to the same pathway via different G proteins in different 
cell types.3 Considering high similarity of A2AAR and A2BAR (72%), especially at the G 
protein coupling interface (Supporting Information, Figure S13B), we assume that the 
A2AAR would also couple to both the Gs and Gi proteins.
With low-energy conformations of AR-G protein complexes obtained from the GaMD 
simulations, further analysis revealed that complementary residue interactions were key for 
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specific GPCR-G protein coupling. When coupling to different G proteins, one receptor 
could change its conformation and flexibility (notably in the TM6 intracellular domain), 
similarly for one G protein as coupled to different receptors (Figures 1 and 6). Provided 
highly complementary residue interactions at the interface, the A2AAR could strongly 
couple to the Gs protein in addition to the Gi. However, coupling of the A1AR to the Gs 
protein became weaker than to the Gi, due to significantly reduced residue interactions 
(Figure 5). The complementary residue interactions were identified to involve the receptor 
TM6, TM5, H8 and ICL2, as well as the Gα α5 helix, α4-β6 loop and αN-β1 loop. These 
regions have been highlighted to be important determinants for specific GPCR-G protein 
coupling in extensive experimental and computational studies as reviewed earlier.12-14, 68
In summary, the GaMD simulations with unconstrained enhanced sampling and free energy 
calculations have provided important insights into the mechanism of specific G protein 
coupling to the A1AR and A2AAR. Nevertheless, effects of the missing ICL3, the engineered 
Gs, the binding different extracellular ligands (e.g., agonists of varied potencies and 
allosteric modulators) on the GPCR-G protein interactions and validation of our simulation 
findings through biochemical and cellular experiments (notably site-directed mutagenesis) 
are subject to future studies. Furthermore, challenges remain to accurately predict the 
thermodynamic and kinetic properties of the G protein binding to the GPCRs in order to 
fully understand the dynamics of GPCR-G protein interactions. It is important to 
characterize both the association and dissociation pathways of the G protein coupling to 
GPCRs. Developments in computing power and enhanced simulation methodologies will be 
needed to address these problems in the future.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Comparison of structural flexibility of active adenosine receptor-G protein complexes 
obtained from GaMD simulations: (A) Change in the root-mean-square fluctuations 
(RMSFs) of the A1AR when the Gi protein was changed to the Gs protein. (B) Change in the 
RMSFs of the A2AAR when the Gs protein was changed to the Gi protein. (C) Change in the 
RMSFs of the Gs protein when the receptor was changed from the A2AAR to the A1AR. (D) 
Change in the RMSFs of the Gi protein when the receptor was changed from the A1AR to 
the A2AAR. A color scale of 0.0 Å (blue) to 1.5 Å (red) is used.
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2D potential of mean force (PMF) profiles of the (A) A1AR-Gi, (B) A2AAR-Gs, (C) 
A2AAR-Gi and (D) A1AR-Gs complex systems regarding the agonist RMSD relative to the 
cryo-EM conformation and AR:NPxxY-G:α5 distance. The white triangles indicate the 
cryo-EM or simulation starting structures.
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Distinct active conformations of the A1AR induced by binding of the Gs protein: (A) 
Representative conformations of two low-energy binding poses of ADO (L1 and L2 in green 
and red, respectively) in the A1AR-Gs complex. The cryo-EM structure of the A1AR-Gi 
complex (PDB: 6D9H, blue) is shown for comparison. (B) Representative conformations of 
open (PDB: 6D9H, blue), semi-open (green) and closed (red) states of ECL2 in the A1AR. 
(C) Representative conformations of the A1AR in the “Active” (blue) and “Over-active” 
(red) states in the A1AR-Gs system.
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Distinct low-energy conformational states of the A1AR-Gs system were identified from 
GaMD simulations. (A) 2D PMF of RMSD of the helix region in ECL2 relative to the cryo-
EM structure and the A1AR: NPxxY-G: α5 distance. (B) 2D PMF of the R3.50-E6.30 and 
A1AR: NPxxY-G: α5 distances. (C) 2D PMF of the orientation angle of the Gα α5 helix 
and the R3.50-E6.30 distance. (D) 2D PMF of the increase of the Gα-Gβ distance and the 
R3.50-E6.30 distance. The white triangles indicate the cryo-EM or simulation starting 
structures.
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Complementary residue interactions at the protein interface in the (A) A1AR-Gi, (B) 
A2AAR-Gs, (C) A2AAR-Gi and (D) A1AR-Gs (active state) systems. The representative low-
energy conformations of the complexes were used to calculate these interaction contacts. 
Hydrogen bond, van der Waals and salt-bridge interactions are colored in red, black and 
blue, respectively. The line thickness is proportional to the number of residue interaction 
pairs. Hydrophobic, polar, acidic and basic residues are colored in green, yellow, red and 
blue, respectively. For receptors, the BW numbers are used for residues in the TM helices 
and the original index numbers for residues in the receptor loops. For the G proteins, the 
residue one letter code and original index number are labeled in the first row and the residue 
CGN number in the second row.
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Summary of specific AR-G protein interactions: (A) the ADO-bound A1AR prefers to bind 
the Gi protein to the Gs. The latter could not stabilize agonist ADO binding in the A1AR and 
tended to dissociate from the receptor. (B) The A2AAR could bind both the Gs and Gi 
proteins, which adopted distinct conformations in the complexes.
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Table 1
Summary of GaMD simulations performed on the agonist-bound AR-G protein complexes.
System A1AR-Gi A2AAR-Gs A2AAR-Gi A1AR-Gs 
e
Dimension (Å3) 112x124x150 110x124x148 110x124x148 108x124x153
Natoms 180,394 175,140 176,028 176,940
Simulation Length (ns) 300 x 3 300 x 3 300 x 3 300 x 3
Boost Potential (kcal/mol) 21.43 ± 6.50 21.12 ± 6.49 20.96 ± 6.41 21.88 ± 6.58
Cryo-EM/Simulation starting structures




16.3 18.4 18.4 16.3
α5 Orientation Angle c (°) 143.9 123.5 147.2 129.8
GaMD simulation low-energy conformations
AR:NPxxY-G:α5 Distance (Å) 12.2 13.2 11.2 11.8, 13.5
Arg3.50- Glu6.30 Distance (Å) 17.4 18.2 17.6 17.5, 22.5
α5 Orientation Angle (°) 135.2 127.5 140.2 123.0, 130.0
Increase of Gα-Gβ Distance
d
 (Å)
−1.3 1.5 −0.8 1.2, 3.2
a
The AR:NPxxY-G:α5 distance is the center-of-mass (COM) distance between the receptor NPxxY motif and the last 5 residues of the Gα α5 
helix.
b
The Arg3.50-Glu6.30 distance is the distance between the Cα atoms of conserved residues Arg3.50 and Glu6.30 in the receptors.
c
The α5 orientation angle is the angle between COMs of the receptor orthosteric pocket, the last 5 and first 5 residues of the Gα α5 helix, 
illustrated in Figure S9E.
d
The increase of Gα-Gβ distance is the increase in the distance between COMs of the Gα (excluding the N-terminal helix) and Gβ (excluding the 
C-terminal of β sheet) subunits compared to the cryo-EM structure.
e
Two low energy conformations are identified from the GaMD simulations and thus two values are presented for simulations of the A1AR-Gs 
complex.
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